Chengjian Mm Cao
Research Subjects
Chengjian Mm Cao has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aiai Mm Zhu
Medical Education Department, Hangzhou Hospital for the Prevention and Treatment of Occupational Diseases, Hangzhou, Zhejiang, China
1 shared publication - Baodan Zhang
Department of Health Management, School of Medicine, Hangzhou Normal University, Zhejiang, 310036, Hangzhou, China
1 shared publication Bing Liu
A Department of Chronic and Non-communicable Disease Control and Prevention , Hangzhou Center for Disease Control and Prevention , Zhejiang , P.R. China
1 shared publication- Changfeng Hu
College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People’s Republic of China
1 shared publication Cheng-Da Yuan
E Dermatological department of Zhejiang Chinese Medical University Affiliated Hospital , Kwong Hing/Hangzhou Municipal TCM Hospital , Hangzhou , P.R. China
1 shared publicationFen-Fang Yang
B Department of Central Laboratory/Medical examination center of Hangzhou , The Frist People's Hospital of Hangzhou , Zhejiang , P.R. China
1 shared publication
Latest Publications
- Open Access
- 20 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (8) , e47704
Prevalence and management of hypertension among adults aged 45 and older in mainland China: Insights from the 2020 CHARLS survey
Hypertension is an escalating global public health challenge. This study aimed to assess the prevalence, awareness, treatment, and management of hypertension, particularly the role of primary healthcare facilities, in individuals aged ≥ 45 years in mainland China. Data were derived from the 2020 baseline survey of the China Health and Retirement Longitudinal Study, comprising 19,282 participants. Statistical analyses were performed using SPSS Statistics 25.0 (Chicago), to examine hypertension prevalence across different demographic subgroups, along with detection rates, treatment status, and utilization of medical and health services. The overall prevalence of hypertension in the study population was 37.73%, with rates increasing with age and peaking in the 85 to 94 age group. While no statistically significant differences were found by gender, region, or education level, prevalence was markedly higher among individuals of the Uygur, Tibetan, and Mongolian ethnicities. Divorced or widowed individuals exhibited significantly higher hypertension rates than those of other marital statuses. Notably, 27.25% of hypertensive individuals were diagnosed through routine physical examination. Regarding disease management, 78.9% of hypertensive patients reported using one or more antihypertensive medications, and 77.9% believed that their blood pressure was well controlled. On average, 72.6% of patients received blood pressure monitoring services at primary healthcare facilities approximately 11.91 ± 4.36 times per year. However, <50% of the patients reported receiving health education for the prevention of hypertension-related complications. Hypertension is highly prevalent among middle-aged and older adults in Mainland China. Enhancing the effectiveness of primary healthcare services is essential to improve the diagnosis and treatment of hypertension. Greater efforts are needed to strengthen health education, raise public awareness, and promote self-management among patients to reduce the burden of hypertension and its associated complications.
- 20 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (8) , e47704
Open AccessPrevalence and management of hypertension among adults aged 45 and older in mainland China: Insights from the 2020 CHARLS survey
Hypertension is an escalating global public health challenge. This study aimed to assess the prevalence, awareness, treatment, and management of hypertension, particularly the role of primary healthcare facilities, in individuals aged ≥ 45 years in mainland China. Data were derived from the 2020 baseline survey of the China Health and Retirement Longitudinal Study, comprising 19,282 participants. Statistical analyses were performed using SPSS Statistics 25.0 (Chicago), to examine hypertension prevalence across different demographic subgroups, along with detection rates, treatment status, and utilization of medical and health services. The overall prevalence of hypertension in the study population was 37.73%, with rates increasing with age and peaking in the 85 to 94 age group. While no statistically significant differences were found by gender, region, or education level, prevalence was markedly higher among individuals of the Uygur, Tibetan, and Mongolian ethnicities. Divorced or widowed individuals exhibited significantly higher hypertension rates than those of other marital statuses. Notably, 27.25% of hypertensive individuals were diagnosed through routine physical examination. Regarding disease management, 78.9% of hypertensive patients reported using one or more antihypertensive medications, and 77.9% believed that their blood pressure was well controlled. On average, 72.6% of patients received blood pressure monitoring services at primary healthcare facilities approximately 11.91 ± 4.36 times per year. However, <50% of the patients reported receiving health education for the prevention of hypertension-related complications. Hypertension is highly prevalent among middle-aged and older adults in Mainland China. Enhancing the effectiveness of primary healthcare services is essential to improve the diagnosis and treatment of hypertension. Greater efforts are needed to strengthen health education, raise public awareness, and promote self-management among patients to reduce the burden of hypertension and its associated complications.
- Open Access
- 30 June 2018
- Published by Springer Nature in Environmental Health and Preventive Medicine
- Vol. 23 (1) , 29
Interactions between ALDH2 rs671 polymorphism and lifestyle behaviors on coronary artery disease risk in a Chinese Han population with dyslipidemia: A guide to targeted heart health management
Both aldehyde dehydrogenase 2 (ALDH2) rs671 polymorphism and lifestyle behaviors are involved in coronary artery disease (CAD), while the interaction between them is currently unknown. A nested case-control study was conducted in 161 patients with CAD and 495 controls in dyslipidemia population in Yinzhou District, Ningbo, Zhejiang Province, China, in August 2013. Anthropometric data and blood samples were collected, demographic characteristics and lifestyle behaviors information were obtained by a face-to-face interview, dietary intake was assessed by a food frequency questionnaire, and genomic DNA was genotyped. Carriers with increasing number of A alleles had an elevated CAD risk compared with G allele carriers (adjusted OR = 1.483, 95% CI = 1.114–1.974). Carriers of rs671 A/G and A/A genotypes had a higher CAD risk than carriers of G/G genotype (adjusted OR = 1.492, 95% CI = 1.036–2.148). Similarly, individuals with rs671 A/A genotype had a higher CAD risk than individuals with A/G and G/G genotypes (adjusted OR = 2.161, 95% CI = 1.139–4.101). We found a borderline additive interaction between regular fried food intake and A/A and A/G genotypes, and a significantly additive interaction between sedentary/light physical activity and A/A and A/G genotypes. Individuals with A/A or A/G genotypes of rs671 have a higher CAD risk, if they lack physical activity and take fried food regularly, than individuals with G/G genotypes. These findings can help to provide a guide to targeted heart health management.
- 30 June 2018
- Published by Springer Nature in Environmental Health and Preventive Medicine
- Vol. 23 (1) , 29
Open AccessInteractions between ALDH2 rs671 polymorphism and lifestyle behaviors on coronary artery disease risk in a Chinese Han population with dyslipidemia: A guide to targeted heart health management
Both aldehyde dehydrogenase 2 (ALDH2) rs671 polymorphism and lifestyle behaviors are involved in coronary artery disease (CAD), while the interaction between them is currently unknown. A nested case-control study was conducted in 161 patients with CAD and 495 controls in dyslipidemia population in Yinzhou District, Ningbo, Zhejiang Province, China, in August 2013. Anthropometric data and blood samples were collected, demographic characteristics and lifestyle behaviors information were obtained by a face-to-face interview, dietary intake was assessed by a food frequency questionnaire, and genomic DNA was genotyped. Carriers with increasing number of A alleles had an elevated CAD risk compared with G allele carriers (adjusted OR = 1.483, 95% CI = 1.114–1.974). Carriers of rs671 A/G and A/A genotypes had a higher CAD risk than carriers of G/G genotype (adjusted OR = 1.492, 95% CI = 1.036–2.148). Similarly, individuals with rs671 A/A genotype had a higher CAD risk than individuals with A/G and G/G genotypes (adjusted OR = 2.161, 95% CI = 1.139–4.101). We found a borderline additive interaction between regular fried food intake and A/A and A/G genotypes, and a significantly additive interaction between sedentary/light physical activity and A/A and A/G genotypes. Individuals with A/A or A/G genotypes of rs671 have a higher CAD risk, if they lack physical activity and take fried food regularly, than individuals with G/G genotypes. These findings can help to provide a guide to targeted heart health management.
- 30 October 2017
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 40 (1) , 16-21
A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups
Background: The obesity-hypertension pathogenesis is complex. From the phenotype to molecular mechanism, there is a long way to clarify the mechanism. To explore the association between obesity and hypertension, we correlate the phenotypes such as the waist circumference (WC), body mass index (BMI), systolic blood pressure (SB), and diastolic blood pressure (DB) with the clinical laboratory data between four specific Chinese adult physical examination groups (newly diagnosed untreated just-obesity group, newly diagnosed untreated obesity-hypertension group, newly diagnosed untreated just-hypertension group, and normal healthy group), and the results may show something. Objective: To explore the mechanisms from obesity to hypertension by analyzing the correlations and differences between WC, BMI, SB, DB, and other clinical laboratory data indices in four specific Chinese adult physical examination groups. Methods: This cross-sectional study was conducted from September 2012 to July 2014, and 153 adult subjects, 34 women and 119 men, from 21 to 69 years, were taken from four characteristic Chinese adult physical examination groups (newly diagnosed untreated just-obesity group, newly diagnosed untreated obesity-hypertension group, newly diagnosed untreated just-hypertension group, and normal healthy group). The study was approved by the ethics committee of Hangzhou Center for Disease Control and Prevention. WC, BMI, SB, DB, and other clinical laboratory data were collected and analyzed by SPSS. Results: Serum levels of albumin (ALB),alanine aminotransferase (ALT), low density lipoprotein cholesterol (LDLC), triglyceride (TG), high density lipoprotein cholesterol (HDLC), alkaline phosphatase (ALP), uric acid (Ua), and TC/HDLC (odds ratio) were statistically significantly different between the four groups. WC statistically significantly positively correlated with BMI, ALT, Ua, and serum levels of glucose (GLU), and TC/HDLC, and negatively with ALB, HDLC, and serum levels of conjugated bilirubin (CB). BMI was statistically significantly positively related to ALT, Ua, LDLC, WC, and TC/HDLC, and negatively to ALB, HDLC, and CB. DB statistically significantly positively correlated with ALP, BMI, and WC. SB was statistically significantly positively related to LDLC, GLU, serum levels of fructosamine (FA), serum levels of the total protein (TC), BMI, and WC. Conclusion: The negative body effects of obesity are comprehensive. Obesity may lead to hypertension through multiple ways by different percents. GGT, serum levels of gamma glutamyltransferase; ALB, serum levels of albumin; ALT, serum levels of alanine aminotransferase; LDLC, serum levels of low density lipoprotein cholesterol; TG, serum levels of triglyceride; HDLC, serum levels of high density lipoprotein cholesterol; FA, serum levels of fructosamine; S.C.R, serum levels of creatinine; IB, serum levels of indirect bilirubin; ALP, serum levels of alkaline phosphatase; CB, serum levels of conjugated bilirubin; UREA, Urea; Ua, serum levels of uric acid; GLU, serum levels of glucose; TC, serum levels of the total cholesterol; TB, serum levels of the total bilirubin; TP, serum levels of the total protein; TC/HDLC, TC/HDLC ratio.
- 30 October 2017
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 40 (1) , 16-21
A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups
Background: The obesity-hypertension pathogenesis is complex. From the phenotype to molecular mechanism, there is a long way to clarify the mechanism. To explore the association between obesity and hypertension, we correlate the phenotypes such as the waist circumference (WC), body mass index (BMI), systolic blood pressure (SB), and diastolic blood pressure (DB) with the clinical laboratory data between four specific Chinese adult physical examination groups (newly diagnosed untreated just-obesity group, newly diagnosed untreated obesity-hypertension group, newly diagnosed untreated just-hypertension group, and normal healthy group), and the results may show something. Objective: To explore the mechanisms from obesity to hypertension by analyzing the correlations and differences between WC, BMI, SB, DB, and other clinical laboratory data indices in four specific Chinese adult physical examination groups. Methods: This cross-sectional study was conducted from September 2012 to July 2014, and 153 adult subjects, 34 women and 119 men, from 21 to 69 years, were taken from four characteristic Chinese adult physical examination groups (newly diagnosed untreated just-obesity group, newly diagnosed untreated obesity-hypertension group, newly diagnosed untreated just-hypertension group, and normal healthy group). The study was approved by the ethics committee of Hangzhou Center for Disease Control and Prevention. WC, BMI, SB, DB, and other clinical laboratory data were collected and analyzed by SPSS. Results: Serum levels of albumin (ALB),alanine aminotransferase (ALT), low density lipoprotein cholesterol (LDLC), triglyceride (TG), high density lipoprotein cholesterol (HDLC), alkaline phosphatase (ALP), uric acid (Ua), and TC/HDLC (odds ratio) were statistically significantly different between the four groups. WC statistically significantly positively correlated with BMI, ALT, Ua, and serum levels of glucose (GLU), and TC/HDLC, and negatively with ALB, HDLC, and serum levels of conjugated bilirubin (CB). BMI was statistically significantly positively related to ALT, Ua, LDLC, WC, and TC/HDLC, and negatively to ALB, HDLC, and CB. DB statistically significantly positively correlated with ALP, BMI, and WC. SB was statistically significantly positively related to LDLC, GLU, serum levels of fructosamine (FA), serum levels of the total protein (TC), BMI, and WC. Conclusion: The negative body effects of obesity are comprehensive. Obesity may lead to hypertension through multiple ways by different percents. GGT, serum levels of gamma glutamyltransferase; ALB, serum levels of albumin; ALT, serum levels of alanine aminotransferase; LDLC, serum levels of low density lipoprotein cholesterol; TG, serum levels of triglyceride; HDLC, serum levels of high density lipoprotein cholesterol; FA, serum levels of fructosamine; S.C.R, serum levels of creatinine; IB, serum levels of indirect bilirubin; ALP, serum levels of alkaline phosphatase; CB, serum levels of conjugated bilirubin; UREA, Urea; Ua, serum levels of uric acid; GLU, serum levels of glucose; TC, serum levels of the total cholesterol; TB, serum levels of the total bilirubin; TP, serum levels of the total protein; TC/HDLC, TC/HDLC ratio.